Most radiologists report few meaningful clinical benefits from current breast imaging AI tools, despite rising adoption.
Key Details
- 1Survey of Society of Breast Imaging members evaluated FDA-cleared breast cancer AI detection tool adoption and impact.
- 2Few radiologists believe current AI contributes significant clinical benefits or decisively improves outcomes.
- 3Although daily use is rising, most users report only minor improvements and little to no financial gain.
- 4A related EuroAIM/EuSoMII 2024 survey found nearly half of respondents use AI, but most saw minimal workload reduction.
- 5Anticipated benefits, like improved outcomes or efficiency, are not widely realized so far in clinical practice.
Why It Matters
This suggests a gap between the promise of AI in breast imaging and its real-world impact, informing future research, tool development, and adoption strategies. Understanding these limitations can guide expectations and investment in imaging AI.
Source
Radiology Business
Related News
•AuntMinnie
Vast Majority of FDA-Cleared Radiology AI Devices Lack Outcome Trials
Only 0.3% of FDA-cleared radiology AI devices have registered trials on patient outcomes, raising concerns about evidence standards.
•AuntMinnie
AI Framework Boosts MRI Quality Control for Prostate Cancer
A deep learning AI framework improved radiologist and model accuracy for prostate cancer detection by assessing MRI image quality.
•Cardiovascular Business
AI Finds Hidden Aortic Stenosis in Routine Chest CTs
AI algorithms can identify undiagnosed aortic stenosis on routine chest CT scans, potentially improving early detection and patient care.